Insider Trading & Ownership of Alison L. Hannah

Location
Fort Myers, FL
Summary
The estimated net worth of Alison L. Hannah is at least $1,448,309 dollars as of 03 Jun 2025. Alison L. Hannah is the Director of NEOGENOMICS INC and owns shares of NEOGENOMICS INC (NEO) stock worth about $1.2M. Alison L. Hannah is the Director of RIGEL PHARMACEUTICALS INC and owns shares of RIGEL PHARMACEUTICALS INC (RIGL) stock worth about $202.5K. Alison L. Hannah is the Chief Medical Officer of CytomX Therapeutics, Inc. and owns shares of CytomX Therapeutics, Inc. (CTMX) stock worth about $44K.
Signature
/s/ Ali Olivo, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Alison L. Hannah and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Quick Takeaways

  • Alison L. Hannah has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $1,448,309.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: NEOGENOMICS INC ($1,201,755).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Alison L. Hannah

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NEO NEOGENOMICS INC Director $1,201,755 01 Jun 2025
RIGL RIGEL PHARMACEUTICALS INC Director $202,512 23 May 2025
CTMX CytomX Therapeutics, Inc. Chief Medical Officer $44,042 19 Jul 2022

Insider Transactions Reported by Alison L. Hannah:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .